To explore the peripheral blood markers of diagnosis and curative effect evaluation in depressive disorder: an observational study

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900028058

Enrollment

Unknown

Registered

2019-12-09

Start date

2019-12-10

Completion date

Unknown

Last updated

2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive disorder

Interventions

Gold Standard:Clinical outcomes

Index test:exosomes circRNA

Eligibility

Sex/Gender

All

Age

14 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) aged 14-65 years; (2) graduate from primary school and above; (3) meet the diagnostic criteria of DSM-5 depressive disorder; (4) voluntary participation, and sign by the legal guardian informed consent.

Exclusion criteria

Exclusion criteria: (1) take any antidepressant, anxiety and psychiatric drugs for the first 3 months of the group, and have negative life events in the first 6 months of the group; (2) comorbidity other severe mental disorders, such as schizophrenia, bipolar disorder, substance use disorders.

Design outcomes

Primary

Measure	Time frame
exosomes circRNA;	—

Secondary

Measure	Time frame
Symptoms;HAMA scale;HAMD scale;	—

Countries

China

Contacts

Public ContactLiu Zhonglin

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

zhonglinliu@126.com+86 13719438236

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026